Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001968554-26-000005

Chief Medical Officer sold 828 shares at $21.89 ($18,128)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jordan Julie Chief Medical Officer 2026-03-26 Sale 10b5-1 −828 $21.89 $18,128 12,472 D: show line 1 in the form
Open-market sales · 828 sh · avg $21.89 · $18,128
Loading xslF345X06/wk-form4_1774905406.xml…